HIV and Pregnancy
Introduction to HIV Transmission Risk
- Individuals with suppressed HIV viral loads can safely have children with extremely low risk of mother-to-child transmission when appropriate medical care is provided, as recommended by the Centers for Disease Control and Prevention 1, 2
- Perinatal HIV transmission is now a preventable disease when pregnant women receive appropriate antiretroviral therapy (ART) and achieve viral suppression, according to the Clinical Infectious Diseases guidelines 2
- Transmission rates have been reported to be less than 1% in women who achieve undetectable HIV viral loads while receiving treatment, as stated by the Clinical Infectious Diseases guidelines 2
Preconception Planning and Care
- The Centers for Disease Control and Prevention recommends selection of effective contraception until optimal health status for pregnancy is achieved, as well as education about perinatal transmission risks and strategies to reduce those risks 3
- Initiation or modification of antiretroviral therapy is recommended to avoid agents with potential reproductive toxicity, choose agents effective in reducing perinatal HIV transmission, attain stable, maximally suppressed maternal viral load, and evaluate and control for therapy-associated side effects that may affect maternal/fetal outcomes, as suggested by the MMWR Recommendations and Reports 3
- For serodiscordant couples, treatment of the HIV-infected partner with suppressive ART is the foundation of safer conception, and home artificial insemination can effectively avoid risk to the uninfected male partner, according to the Clinical Infectious Diseases guidelines 4
Management During Pregnancy
- The Centers for Disease Control and Prevention recommends that all pregnant women with HIV should be treated with antiretroviral therapy regardless of their immunologic or virologic status, with a minimum of zidovudine (ZDV) prophylaxis given even to women with very low or undetectable viral loads 2, 3
- Antiretroviral prophylaxis reduces transmission even among women with HIV RNA levels <1,000 copies/mL, and coordination between HIV specialists and obstetricians is essential for optimal care, as stated by the MMWR Recommendations and Reports 3
Postpartum and Infant Care
- The World Health Organization recommends that infants born to HIV-positive mothers should receive antiretroviral postexposure prophylaxis as soon as possible after birth, and HIV-infected women should be instructed not to breastfeed in settings where safe alternatives are available, to minimize transmission risk 4
- Infants should undergo HIV virologic testing according to established guidelines, as recommended by the Clinical Infectious Diseases guidelines 2
Potential Challenges and Considerations
- Adherence to antiretroviral therapy is crucial for maintaining viral suppression and preventing transmission, and regular viral load monitoring during pregnancy is important to confirm ongoing suppression, as suggested by the MMWR Recommendations and Reports 5, 6
- Women should be monitored for potential side effects of antiretroviral drugs that could affect maternal or fetal health, and long-term follow-up of children with in utero antiretroviral exposure is important as late consequences are not fully known, according to the MMWR Recommendations and Reports 3, 7